DirectorsTalk LSE Stock market news, financial, press release, articles and interviews 
The goal of Advanced Oncotherapy (LON:AVO) is to deliver an affordable and more effective proton beam therapy (PBT) system, based on state-of-the-art technology developed originally at the world-renowned CERN. In ...
Read Article »Home » Hardman Research
Hardman Research
-
Palace Capital 1H’20 results announced
-
Artificial Solutions Conversational AI leader; customer wins continue
-
Pantheon International Plc History of value added to portfolio by holding Pantheon
-
Diurnal Group Plc Successful DITEST Phase I trial outcome
-
Genedrive Regulatory hurdle leaped: hearing loss assay
-
Incanthera Ltd Realising near-term value in oncology
-
Chamberlin Management actions yield cautious optimism
-
Non-Standard Finance Trading update: understand the accounting
-
Neodecortech Robustly positioned for 2019/20
-
Advanced Oncotherapy FLASH benefits from new US reimbursement
-
Nexus Investments’ Scale-Up Fund
-
Filta Group FY19 trading update
-
Diurnal Group Approaching a number of near-term milestones
-
Shield Therapeutics Plc More choice for clinicians and patients
-
REA Holdings Weak commodity prices dampen road to recovery
-
Surface Transforms Recent major contract wins transform prospects
-
Haydale Graphene Industries Cost savings evident, revenue growth to come
-
PHOENIX COPPER LTD First stage in potential world-class copper mine
-
REAL ESTATE CREDIT INVESTMENTS 7%+ yield from well-secured property debt portfolio
-
ARTIFICIAL SOLUTIONS 2Q’19 results – customer wins, accelerating order intake
-
ADVANCED ONCOTHERAPY Nearing the end goal
-
SHIELD THERAPEUTICS FDA approval opens door to major US opportunity
-
PRIMARY HEALTH PROPERTIES High security and accelerating dividend growth
-
Burford Capital Results don’t need to be appealed
-
Gateley Plc Excellent full-year results
-
ARBUTHNOT BANKING GROUP 1H’19 results: diversified, low-risk growth continues
-
Koovs Plc New year started with a bang
-
City of London Investment Group Finishing ahead in a volatile year for markets
-
Redx Pharma Phase I trial resumed
-
Burford Capital Petersen appeals to investors
-
Arbuthnot Banking Group Plc Mortgage portfolio acquisitions
-
Oxford BioMedica Eying up long-term value
-
Allergy Therapeutics plc Successful legal outcome removes uncertainty
-
Volta Finance Manager’s Hardman & Co Forum presentation
-
Oxford BioMedica De-leveraging the balance sheet
-
Tissue Regenix Credit facilities expand cash runway to 2021
-
Non-Standard Finance Back to basics
-
IPSX The first regulated property exchange in the world
-
Anglo Asian Mining Prodigious cashflow AND bigger “system” potential
-
R.E.A. Holdings Strong production continues; deferred 1H pref. dividend
